Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Aclaris Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Monte Rosa Therapeutics Inc. June 11, 202699.0%
-
Aclaris Therapeutics Inc. June 5, 202598.6%
-
Monte Rosa Therapeutics Inc. June 14, 202395.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 5, 2026 | Aclaris Therapeutics Inc. | Option exercise | +11,580 | — | — |
| Jun 6, 2025 | Aclaris Therapeutics Inc. | Option exercise | +4,793 | — | — |
| Jun 1, 2024 | Aclaris Therapeutics Inc. | Option exercise | +4,660 | — | — |
| Jun 2, 2023 | Aclaris Therapeutics Inc. | Option exercise | +4,507 | — | — |
Questions about Andrew N. Schiff
What boards is Andrew N. Schiff on?
Andrew N. Schiff sits on the boards of Aclaris Therapeutics Inc. and Monte Rosa Therapeutics Inc.
How long has Andrew N. Schiff served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.